Clinical trial
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in…
NCT00485303 · Cougar Biotechnology, Inc., Industry · Completed
Key facts
| NCT number | NCT00485303 |
|---|---|
| Title | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy |
| Official title | A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy |
| Lead sponsor | Cougar Biotechnology, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Abiraterone acetate, Prednisone |
| Enrollment | 58 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jun 12, 2007 |
| Last update posted | Jul 2, 2013 |
| Countries | United Kingdom, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: